These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 29179855)
1. Analysis of the influence of the T393C polymorphism of the GNAS gene on the clinical expression of primary hyperparathyroidism. Piedra M; Berja A; Ramos L; García-Unzueta MT; Morán JM; Ruiz D; Amado JA Endocrinol Diabetes Nutr; 2017 Dec; 64(10):524-530. PubMed ID: 29179855 [TBL] [Abstract][Full Text] [Related]
2. "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density". Piedra M; García-Unzueta MT; Berja A; Paule B; Lavín BA; Valero C; Riancho JA; Amado JA BMC Med Genet; 2011 Dec; 12():168. PubMed ID: 22185226 [TBL] [Abstract][Full Text] [Related]
3. Rs219780 SNP of Claudin 14 Gene is not Related to Clinical Expression in Primary Hyperparathyroidism. Piedra M; Berja A; García-Unzueta MT; Ramos L; Valero C; Amado JA Clin Lab; 2015; 61(9):1197-203. PubMed ID: 26554238 [TBL] [Abstract][Full Text] [Related]
4. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801 [TBL] [Abstract][Full Text] [Related]
6. 1,25-dihydroxyvitamin D and the vitamin D receptor gene polymorphism Apa1 influence bone mineral density in primary hyperparathyroidism. Christensen MH; Apalset EM; Nordbø Y; Varhaug JE; Mellgren G; Lien EA PLoS One; 2013; 8(2):e56019. PubMed ID: 23418495 [TBL] [Abstract][Full Text] [Related]
7. Clinical phenotypes of Chinese primary hyperparathyroidism patients are associated with the calcium-sensing receptor gene R990G polymorphism. Han G; Wang O; Nie M; Zhu Y; Meng X; Hu Y; Liu H; Xing X Eur J Endocrinol; 2013 Nov; 169(5):629-38. PubMed ID: 23946278 [TBL] [Abstract][Full Text] [Related]
9. Association between parathyroid hormone (PTH)/PTH-related peptide receptor gene polymorphism and the extent of bone mass reduction in primary hyperparathyroidism. Kanzawa M; Sugimoto T; Kobayashi T; Kobayashi A; Chihara K Horm Metab Res; 2000 Sep; 32(9):355-8. PubMed ID: 11014383 [TBL] [Abstract][Full Text] [Related]
10. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation. Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779 [TBL] [Abstract][Full Text] [Related]
11. Lack of association of the genotype in the GNAS Fok I polymorphism and prostate cancer. Eisenhardt A; Scherag A; Jöckel KH; Reis H; Rübben H; Siffert W Urol Int; 2011; 87(1):80-6. PubMed ID: 21677417 [TBL] [Abstract][Full Text] [Related]
12. The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism. Kaji H; Yamauchi M; Chihara K; Sugimoto T Eur J Endocrinol; 2005 Sep; 153(3):373-8. PubMed ID: 16131599 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D status affects osteopenia in postmenopausal patients with primary hyperparathyroidism. Inoue Y; Kaji H; Hisa I; Tobimatsu T; Naito J; Iu MF; Sugimoto T; Chihara K Endocr J; 2008 Mar; 55(1):57-65. PubMed ID: 18187872 [TBL] [Abstract][Full Text] [Related]
14. Bone metabolism in patients with primary hyperparathyroidism before and after surgery. Kerschan-Schindl K; Riss P; Krestan C; Rauner M; Bieglmayer C; Gleiss A; Fialka-Moser V; Niederle B; Pietschmann P Horm Metab Res; 2012 Jun; 44(6):476-81. PubMed ID: 22495973 [TBL] [Abstract][Full Text] [Related]
15. Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism. Lee JH; Kim JH; Hong AR; Kim SW; Shin CS Osteoporos Int; 2017 May; 28(5):1667-1674. PubMed ID: 28175978 [TBL] [Abstract][Full Text] [Related]
16. Polymorphisms at the regulatory regions of the CASR gene influence stone risk in primary hyperparathyroidism. Vezzoli G; Scillitani A; Corbetta S; Terranegra A; Dogliotti E; Guarnieri V; Arcidiacono T; Paloschi V; Rainone F; Eller-Vainicher C; Borghi L; Nouvenne A; Guerra A; Meschi T; Allegri F; Cusi D; Spada A; Cole DE; Hendy GN; Spotti D; Soldati L Eur J Endocrinol; 2011 Mar; 164(3):421-7. PubMed ID: 21183554 [TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics of Primary Hyperparathyroidism: 15-Year Experience of 457 Patients in a Single Center in China. Lin X; Fan Y; Zhang Z; Yue H Front Endocrinol (Lausanne); 2021; 12():602221. PubMed ID: 33716964 [TBL] [Abstract][Full Text] [Related]
18. Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Moosgaard B; Christensen SE; Vestergaard P; Heickendorff L; Christiansen P; Mosekilde L Clin Endocrinol (Oxf); 2008 May; 68(5):707-15. PubMed ID: 17980013 [TBL] [Abstract][Full Text] [Related]
19. The Möhlendick B; Schmid KW; Siffert W Pharmacogenomics; 2019 May; 20(7):553-562. PubMed ID: 31124412 [TBL] [Abstract][Full Text] [Related]
20. Homozygous GNAS 393C-allele carriers with locally advanced esophageal cancer fail to benefit from platinum-based preoperative chemoradiotherapy. Alakus H; Bollschweiler E; Hölscher AH; Warnecke-Eberz U; Frazer KA; Harismendy O; Lowy AM; Mönig SP; Eberz PM; Maus M; Drebber U; Siffert W; Metzger R Ann Surg Oncol; 2014 Dec; 21(13):4375-82. PubMed ID: 24986238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]